A phase II randomized, observer-blind, placebo-controlled study, to assess efficacy of meningococcal group b vaccine rmenb+OMV NZ (bexsero) in preventing gonococcal infection

Active Cooperative Agreement Awarded Last action

Award ID
HU0001262E075
Recipient
Awarding agency
Obligated
$394,010

Award facts

Assistance listing
12.750 Uniformed Services University Medical Research Projects
Completion date 6% complete
Place of performance
United States

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Uniformed Services University of the Health Sciences awarded a $394,010 cooperative agreement to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. on September 30, 2026 under the Uniformed Services University Medical Research Projects program (CFDA 12.750) to conduct a Phase II randomized, observer-blind, placebo-controlled study assessing the efficacy of meningococcal group B vaccine Rmenb+OMV NZ (Bexsero) in preventing gonococcal infection. Performance occurs in the United States with a period of performance through September 29, 2027. The Henry M. Jackson Foundation serves as the recipient organization, a non-profit research entity headquartered in Bethesda, Maryland that delivers military medical research and clinical studies to Department of Defense and federal health agencies.

Quick answers

Who received award HU0001262E075?

HU0001262E075 was awarded to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. by Uniformed Services University of the Health Sciences (Department of Defense) on September 30, 2026.

How much is award HU0001262E075 worth?

$394,010 has been obligated on HU0001262E075.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login